logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9284335 B1

PDFFull Text
Date of Patent:
Mar. 15, 2016

Filed:

Jun. 18, 2013

Substituted pyrido[3,2-e][1,2,4]triazolo[1,5-c]pyrimidines, pyrido[2,3-e][1,2,4]triazolo[1,5-c]pyrimidines and/or [1,2,4]triazolo[1,5-c]pteridines for treatment of central nervous system diseases and disorders

Applicant:

Dart Neuroscience (Cayman) Ltd., Grand Cayman, KY;

Inventors:

Amy Allan, Encinitas, CA (US);

Bryan Branstetter, Carlsbad, CA (US);

Brian Dyck, San Diego, CA (US);

Laurent Gomez, San Diego, CA (US);

Tami Jo Marrone, Carlsbad, CA (US);

Marco Peters, San Diego, CA (US);

Michael I. Weinhouse, San Diego, CA (US);

Assignee:

Dart NeuroScience (Cayman) Ltd., Grand Cayman, KY;

Attorney:

Knobbe Martens Olson & Bear LLP

Primary Examiner:

Douglas M Willis

Int. Cl.
CPC ...
A61K 31/519 (2006.01); C07D 239/70 (2006.01); C07D 519/00 (2006.01); C07D 495/14 (2006.01); C07D 498/08 (2006.01); C07D 491/147 (2006.01); C07D 491/22 (2006.01); C07D 495/22 (2006.01); C07D 471/14 (2006.01); C07D 487/14 (2006.01); C07D 491/107 (2006.01);
U.S. Cl.
CPC ...
C07D 519/00 (2013.01); C07D 471/14 (2013.01); C07D 487/14 (2013.01); C07D 491/107 (2013.01); C07D 491/147 (2013.01); C07D 491/22 (2013.01); C07D 495/14 (2013.01); C07D 495/22 (2013.01); C07D 498/08 (2013.01);
Abstract

Described herein are compounds and chemical entities of Formula (I), methods of their synthesis, compositions comprising them, and their use in treating numerous diseases and disorders, including cognitive deficits associated with CNS diseases and disorders.

Find Patent Forward Citations

Allan, Amy. (2016). Substituted pyrido[3,2-e][1,2,4]triazolo[1,5-c]pyrimidines, pyrido[2,3-e][1,2,4]triazolo[1,5-c]pyrimidines and/or [1,2,4]triazolo[1,5-c]pteridines for treatment of central nervous system diseases and disorders (U.S. Patent No. 9284335). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9284335

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…